Wright Dara's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Dec 12, 2023
- Accession no.
- 0001062993-23-022476
- Filed
- Dec 12, 2023
- Trade date
- Dec 12, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $359.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wright DaraCIK 0001796980 | Officer (EVP, President, CDG) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | Bio-Rad A Common Stock | SSaleDisposed | −1,200 | $299.16 | −$358,992 | 1,499.08 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.